VNOV: the balance sheet

MyFinsight

VitaNova Life Sciences Corp (VNOV)

Balance Sheets	2026-04-30
Cash	1,597,217
Accounts receivable, net	726,743
Advance to vendors	0
Inventories	105,613
Other current assets	950
Total current assets	2,430,523
Deferred tax assets	16,038
Total noncurrent assets	16,038
Total assets	2,446,561

Accounts payable	208,813
Accrued expenses and other current liabilities	78,959
Income tax payable	108,009
Total current liabilities	395,781
Total liabilities	395,781
Common stock, 0.001 par value 200,000,000 shares authorized 8,337,454 shares issued and outstanding	8,337
Additional paid-in capital	1,029,646
Shares to be issued	182,400
Retained earnings	830,397
Total shareholders' equity	2,050,780
Total liabilities and stockholders' equity	2,446,561

Unit: Dollar.